SCHEMBL17965

SCHEMBL17965

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@@H](CSc2ccccc2)C1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 18/20 0.58
GCK P35557 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17205 0.94 GCKR (0.55) GCKRGCK
SCHEMBL26729 0.92 GCKR (0.53) GCKRGCK
SCHEMBL17897 0.91 GCKR (0.55) GCKRGCK
SCHEMBL16425 0.87 GCKR (0.62) GCKRGCK
SCHEMBL16197 0.87 GCKR (0.62) GCKRGCK
SCHEMBL12090109 0.87 GCKR (0.61) GCKRGCK
SCHEMBL16820 0.86 GCKR (0.61) GCKRGCK
SCHEMBL12078556 0.86 GCK (0.69) GCKRGCK
SCHEMBL16749 0.86 GCK (0.69) GCKRGCK
SCHEMBL18757 0.86 GCK (0.69) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed